Hope Warshaw, MMSc, RD, CDCES, BC-ADM, FADCES, is owner of Hope Warshaw Associates, LLC, a diabetes- and nutrition-focused consultancy based in Asheville, North Carolina
If cost or eligibility is a concern, always consult a GP or healthcare professional before switching treatments
121 Consequently, beinaglutide holds significant promise for advancing research in the areas of overweight/obesity and nonalcoholic steatohepatitis (NASH)
The transaction is expected to close in the second quarter of 2025
Retatrutide targets three hormone receptorsGLP-1, GIP, and glucagonwhile semaglutide only targets GLP-1
Another factor leading to muscle loss is rapid weight loss, which clinical trials show that people on semaglutide may experience